Sundrug Co (9989.T) Stock Price

Sundrug Co Price

JPX·CLOSED
3,530.00
​
Market closed

Over the last 19 years Sundrug Co grew revenue by 7.9% annually, reaching 842.51 B JPY. Earnings per share have grown at 7.8% per year over the last 19 years. For Sundrug Co, the net margin of 3.7% is broadly stable versus 3.7% a few years ago. At today's price the dividend yield works out to roughly 5.55%. The payout ratio is around 49% of earnings. The dividend has grown at 15.8% per year over the past 19 years. The consensus 12-month price target for Sundrug Co is 5,508.00 JPY, about 56.0% above where the stock trades today. Of 13 analysts, 9 rate the stock a buy — an overall Buy consensus.

Sundrug Co stock price

Access this data via the Eulerpool API

Sundrug Co business model & stock analysis

Sundrug Co Ltd is a Japanese company that was founded in Osaka in 1960. It started as a small pharmaceutical company that manufactured and sold over-the-counter medications and health products. Over the years, Sundrug has developed into a leading company in the Japanese health market. The business model of Sundrug is based on a comprehensive offering of health products and services. The company operates a variety of stores, including drugstores, pharmacies, supermarkets, and shopping centers, where it offers a wide range of products. The company is also involved in the manufacturing and marketing of pharmaceuticals and medical devices, and provides services such as health consultation and nursing care. One of the key divisions of Sundrug is its retail department, with its drugstores and pharmacies. Here, the company offers a wide range of over-the-counter medications, vitamins, and health products. The products range from cosmetic items to dietary supplements to enhance the well-being and health of customers. Another important division of Sundrug is the production of pharmaceutical products. The company manufactures a wide range of medications and medical devices, such as antibiotics, pain relievers, or diabetes medications. As part of its quality control, the company has a strict system for monitoring and testing its products. Sundrug is also active in the service industry and operates some hospitals and care facilities. The company offers consulting services and care services for elderly people. It operates as a non-profit organization and places great emphasis on promoting quality of life and health. The company also has a strong presence in the e-commerce sector. It operates an online platform where customers can conveniently order their health products from home. The company also offers a subscription service for regularly needed medications and products. Another important division of Sundrug is the cosmetic department. Here, the company offers a wide range of beauty products such as skin creams, shampoos, and makeup. The company follows the approach of meeting the needs of customers and offering products suitable for different age groups and skin types. Today, Sundrug is a leading company in the Japanese health market. Over the years, it has built a strong brand image and is known for its high-quality products and excellent services. The company places great emphasis on promoting health and well-being and strives to play a leading role in this market.

Frequently asked questions about Sundrug Co

The business model of Sundrug Co Ltd revolves around operating a chain of retail pharmacies in Japan. Sundrug Co Ltd focuses on providing a wide range of pharmaceutical products, health supplements, and personal care items to its customers. The company also emphasizes offering quality customer service and convenient in-store experiences to enhance customer satisfaction. By prioritizing accessibility, Sundrug Co Ltd aims to cater to the healthcare needs of the local community while maintaining its competitive position in the pharmaceutical retail industry.

Sundrug Co Ltd is primarily active in the pharmaceutical and retail industries.

The main competitors of Sundrug Co Ltd in the market include companies such as Matsumotokiyoshi Holdings Co Ltd, Tomod's Inc, and Cocokara Fine Inc. These companies operate in the same retail pharmaceutical industry and provide similar products and services to customers. Sundrug Co Ltd faces competition in terms of pricing, product variety, and customer service from these industry rivals. However, Sundrug Co Ltd has managed to establish a strong presence and maintain its competitive edge through its extensive network of stores, strategic partnerships, and commitment to customer satisfaction.

Sundrug Co Ltd is a leading pharmaceutical company based in Japan. With a rich history dating back to its establishment in 2002, Sundrug has grown to become a trusted name in the healthcare industry. The company operates a chain of retail pharmacies, providing a wide range of prescription drugs, over-the-counter medications, and health products. Sundrug Co Ltd aims to improve the well-being of its customers by delivering high-quality healthcare services and products. With its commitment to innovation and customer satisfaction, Sundrug continues to expand its presence in the market, making it a reliable choice for all your pharmaceutical needs.

Some significant milestones achieved by Sundrug Co Ltd include its establishment in 1990, successful expansion into various regions of Japan, and becoming one of the leading retail pharmacy chains in the country. The company has consistently focused on quality healthcare services and customer satisfaction. Sundrug Co Ltd has also cultivated strategic partnerships with major pharmaceutical companies, allowing them to offer a wide range of medicines and healthcare products. With a strong emphasis on innovation and community support, Sundrug Co Ltd continues to strengthen its presence in the Japanese healthcare industry.

Sundrug Co Ltd, a leading pharmaceutical company, primarily operates in Japan. With a strong market presence, Sundrug serves customers across various regions in Japan, including Tokyo, Osaka, and Hokkaido. As one of the largest drugstore chains in the country, Sundrug focuses on offering a wide range of medical products and healthcare services to its customers. With its extensive network of stores, Sundrug aims to provide convenient access to quality healthcare solutions for people throughout Japan.

Sundrug Co Ltd is a leading company that upholds strong values and corporate philosophy. They prioritize customer satisfaction by providing high-quality products and services. Sundrug Co Ltd aims to contribute to society through their commitment to health and wellness. Their core values include integrity, professionalism, and innovation. With a focus on teamwork and continuous improvement, Sundrug Co Ltd actively seeks to meet the diverse needs of their customers. By adhering to their corporate philosophy of contributing to a healthy and vibrant society, Sundrug Co Ltd has established a reputable name in the market.

Analysts currently set an average price target of 5,319.87 JPY for the Sundrug Co stock (median: 5,508.00 JPY), implying +50.7 % versus the latest price. The consensus is based on 13 analyst ratings.

13 analysts currently rate the Sundrug Co stock: 9 recommend buying, 4 holding and 0 selling.

Converted at the current exchange rate, the Sundrug Co share trades at 19.91 EUR (3,530.00 JPY).

The Sundrug Co share (9989.T) is listed on 2 stock exchanges, including: Tokio (JPX) (9989.T).

Sundrug Co Ltd is a Japanese company that specializes in selling pharmaceuticals, medical devices, beauty products, and household items. The company operates both retail and wholesale stores to distribute its products on a wide basis.

The revenue of Sundrug Co is 842.51 B JPY. This figure is based on current financial data and reflects the company's business performance.

The profit of Sundrug Co is 31.39 B JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Sundrug Co is currently 13.15. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sundrug Co stock.

The price-to-sales ratio (P/S) of Sundrug Co is currently 0.49. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sundrug Co stock.

The Eulerpool Quality Score for Sundrug Co is 7/10.

The ISIN of Sundrug Co is JP3336600006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Sundrug Co is 895861. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Sundrug Co is 9989.T. The ticker symbol is used to trade Sundrug Co shares on the stock exchange.

Fair ValueTerminal
3,282.90 JPY
Over-/UndervaluationTerminal
Fairly valued
Industry
Food & Staples Retailing
Number of shares
Employees
Revenue per Employee
160.75 M JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
JPY
Initial public offering
Sep 17, 1997
ISIN
JP3336600006
Cusip
J78089109
Sedol
6817895
Market capitalization
412.88 B JPYMega Cap
52-Week Range
PEG
4.60
P/E ratio
P/Ee 2027
12.44
P/Ee 2028
11.63
P/Ee 2029
10.99
P/Ee 2030
11.10
P/Ee 2031
10.81
P/S
P/Se
0.46
EV/EBIT
8.34
P/B Ratio
1.44
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
9.39 %
Dividend
Dividend yield
5.55 %
Est. Dividend Yield
6.66 %
Payout Ratio
49.05 %
Dividend growth Ø5Y
17.91 %
Dividend payments per year
2
Dividend paid since
34 years
Dividend not reduced since
18 years
Dividend increased since
18 years
Dividend withholding tax
15.32 %
Last updated Oct 10, 2026, 10:01 PM

Sundrug Co Ticker

JPX · 9989.TOTC · SDGCF

Sundrug Co FIGI

9989:JP · BBG000DDGGX79989:JT · BBG000DDGHH39989:JJ · BBG000DDGMV69989:JE · BBG000DDGP219989:JI · BBG000DDGP67SDGCF:US · BBG000PG84D5SDGCF:UV · BBG000PG8F319989:JU · BBG002QK96639989:JW · BBG00875FK759989JPY:X2 · BBG00JRRKSD19989JPY:XB · BBG00JRRKSF99989JPY:XH · BBG00JRRKSH7

All fundamentals and in-depth analysis of Sundrug Co

Our stock analysis for Sundrug Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sundrug Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.